SSG
STJ

Summit Securities Group’s St Jude Medical STJ Stock Holding History

Summit Securities Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-4,600
Closed -$359K – 326
2016
Q2 		$359K Buy
+4,600
New +$328K 0.19% 130
2014
Q4 		– Sell
-2,200
Closed -$132K – 812
2014
Q3 		$132K Sell
2,200
-50,700
-96% -$3.31M 0.04% 263
2014
Q2 		$3.66M Buy
52,900
+51,300
+3,206% +$3.33M 1.26% 21
2014
Q1 		$105K Sell
1,600
-6,100
-79% -$397K 0.06% 134
2013
Q4 		$477K Buy
+7,700
New +$446K 0.08% 112

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Summit Securities Group's STJ Position: Q3 2016 in Review

Summit Securities Group sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 4,600 shares — an estimated $359K sold.

Summit Securities Group first reported a position in STJ in Q4 2013 and held it in 5 quarters. The position peaked at $3.66M in Q2 2014. 570 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Summit Securities Group reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Summit Securities Group sold 4,600 St Jude Medical shares in Q3 2016, an estimated $359K.
  • Summit Securities Group first reported a position in St Jude Medical in Q4 2013 and held it in 5 quarters.
  • Summit Securities Group's St Jude Medical position peaked at $3.66M in Q2 2014.
  • 570 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Summit Securities Group's 13F filing for Q3 2016, filed 7 Nov 2016.